Contract HHSN261201600404P
Fujirebio Us, Inc. · Department Of Health And Human Services · June 21, 2016
Fujirebio Us, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 21, 2016 for $9,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN261201600404P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- June 21, 2016
Description
LAB SUPPLIES/FUJIREBIO DIAGNOSTICS,INC/YUKI TAKAMATSU
Modification timeline
-
June 21, 2016Base award$8.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN261201600404P?
Contract HHSN261201600404P is a federal contract awarded to Fujirebio Us, Inc. by Department Of Health And Human Services on June 21, 2016 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSN261201600404P?
Fujirebio Us, Inc. won contract HHSN261201600404P from Department Of Health And Human Services.
How much is contract HHSN261201600404P worth?
Contract HHSN261201600404P has obligated $9,000 to date.